Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: OEIC
  • Objective: European Reg. ex UK
  • Asset Class: Equity
  • Geographic Focus: European Reg. ex UK

F&C Investment Funds ICVC - European Growth & Income Fund

+ Add to Watchlist

RSLEU3I:LN

936.00 GBp 9.60 1.02%

As of 11:24:22 ET on 03/31/2015.

Snapshot for F&C Investment Funds ICVC - European Growth & Income Fund (RSLEU3I)

Year To Date: +12.37% 3-Month: +11.72% 3-Year: +18.13% 52-Week Range: 748.70 - 954.90
1-Month: +4.51% 1-Year: +11.89% 5-Year: +10.39% Beta vs FTWIWXUK: 0.90

Mutual Fund Chart for RSLEU3I

No chart data available.
  • RSLEU3I:LN 936.00
  • 1M
  • 1Y
Interactive RSLEU3I Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for RSLEU3I

F&C Investment Funds ICVC - European Growth & Income Fund is an open-end investment company incorporated in the United Kingdom. The Fund aims to achieve medium to long-term growth and income. The Fund invests primarily in European equities.

Inception Date: 10-25-1999 Telephone: 44-870-601-6183
Managers: MARK NICHOLS
Web Site: www.fandc.co.uk

Fundamentals for RSLEU3I

NAV (on 2015-03-31) 936.00
Assets (M) (on 2014-11-20) 352.88
Fund Leveraged N
Minimum Investment 50,000,000.00
Minimum Subsequent Investment 25,000.00

Dividends for RSLEU3I

Dividend Type Accumulation
Dividend Frequency Annual
Last Dividend Net (on 2014-05-01) 16.95
Dividend Yield (ttm) 2.01

Fees & Expenses for RSLEU3I

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.40
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 0.47

Top Fund Holdings for RSLEU3I

Filing Date: 01/31/2015
Name Position Value % of Total
Novartis AG 329,512 21,502,886 6.197%
Roche Holding AG 87,837 15,805,394 4.555%
Svenska Handelsbanken AB 442,796 14,002,689 4.035%
Allianz SE 115,911 12,749,818 3.674%
Reed Elsevier NV 755,303 12,335,849 3.555%
Wolters Kluwer NV 544,528 10,866,421 3.131%
SAP SE 230,434 10,010,664 2.885%
Unilever NV 343,477 9,958,239 2.870%
Bayer AG 101,437 9,730,620 2.804%
Glanbia PLC 899,649 9,671,083 2.787%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil